Acoustic properties of aspirin in its various phases and transformation stages studied by Brillouin scattering
Source abstract
Abstract
Abstract The acoustic behaviors of aspirin were studied in its crystal, liquid, glass states as well as transformation stages between them. The Brillouin doublet of the longitudinal acoustic (LA) mode propagating to the [100] direction of aspirin crystals showed a splitting in a temperature range of 393–413 K below the melting temperature, which indicated a softening and distortion of the layered aspirin crystal in its premelting stage. One LA mode was observed in the liquid and glassy phases of aspirin, consistent with Brillouin selection rule for isotropic materials. The acoustic damping in the glassy aspirin was systematically higher than that in the crystal aspirin, which was in contrast to ibuprofen materials. These suggested different activity of remnant local dynamics that could couple to the acoustic waves, persistent in the glassy state of these two representative pharmaceuticals. In the supercooled liquid phase, the Brillouin spectrum displayed a new spectral feature characterized by a high-frequency cutoff and a distributed low-frequency contribution other than the Brillouin peak of the amorphous aspirin. This could be ascribed to the formation of crystalline grains in the glassy matrix due to cold crystallization.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Material Dynamics and Properties · Advancements in Transdermal Drug Delivery · Microencapsulation and Drying Processes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (29)
Show source-provided references
1. Johari · Phys. Chem. Chem. Phys. · 2000 · 2 · 547910.1039/b007086f ↗
2. Dyre · Rev. Mod. Phys. · 2006 · 78 · 95310.1103/RevModPhys.78.953 ↗
3. Cang · J. Chem. Phys. · 2005 · 123 · 06450810.1063/1.2000235 ↗
4. Nath · Phys. Rev. E: · 2006 · 74 · 02150610.1103/PhysRevE.74.021506 ↗
5. Johari · J. Pharm. Sci. · 2007 · 96 · 115910.1002/jps.20921 ↗
6. Brás · J. Phys. Chem. B · 2008 · 112 · 1108710.1021/jp8040428 ↗
7. Johar · J. Pharm. Sci. · 2005 · 94 · 220710.1002/jps.20455 ↗
8. Goresy · J. Phys. Condens. Matter · 2007 · 19 · 20513410.1088/0953-8984/19/20/205134 ↗
9. Jansson · Phys. Rev. Lett. · 2010 · 104 · 01780210.1103/PhysRevLett.104.017802 ↗
10. Kim · Chem. Pharm. Bull. · 1985 · 33 · 264110.1248/cpb.33.2641 ↗
11. Aubrey-Medendorp · J. Pharm. Sci. · 2008 · 97 · 136110.1002/jps.21055 ↗
12. Heng · J. Pharm. Sci. · 2007 · 96 · 213410.1002/jps.20841 ↗
13. Ko · Chem. Phys. Lett. · 2008 · 465 · 3610.1016/j.cplett.2008.09.031 ↗
14. Kim · Saemulli: New Physics · 2009 · 58 · 596
15. Hassaine · J. Chem. Phys. · 2009 · 131 · 17450810.1063/1.3258645 ↗
16. Ko · J. Non-Cryst. Solids · 2002 · 307–310 · 15410.1016/S0022-3093(02)01454-0 ↗
17. Ko · J. Opt. Soc. Korean · 2009 · 13 · 26110.3807/JOSK.2009.13.2.261 ↗
18. Ko · J. Korean Phys. Soc. · 2009 · 54 · 84910.3938/jkps.54.849 ↗
19. Watanabe · Chem. Pharmacol. Bull. · 1982 · 30 · 295810.1248/cpb.30.2958 ↗
20. Mountain · J. Res. Nat. Bur. Stand. · 1966 · 70A · 20710.6028/jres.070A.017 ↗
21. Mountain · J. Res. Nat. Bur. Stand. · 1968 · 72A · 9510.6028/jres.072A.011 ↗
22. Sandercock · 1982
23. Cano · J. Cryst. Growth · 2001 · 224 · 33510.1016/S0022-0248(01)00969-1 ↗
24. Perlovich · J. Therm. Anal. Calarim. · 2001 · 63 · 65310.1023/A:1010119532614 ↗
25. K.-S. Lee, J.-H. Ko, and S. Kojima, unpublished.
26. Hernandez · J. Opt. Soc. Am. B: Opt. Phys. · 1996 · 13 · 113010.1364/JOSAB.13.001130 ↗
27. Ko · Jpn. J. Appl. Phys. · 2003 · 42 · 307610.1143/JJAP.42.3076 ↗
28. Patkowski · J. Chem. Phys. · 2007 · 126 · 01450810.1063/1.2426347 ↗
29. Adrjanowicz · J. Phys. Chem. B · 2010 · 114 · 657910.1021/jp910009b ↗